Imagen Technologies, Inc.

Imagen is an AI-enabled diagnostic imaging partner delivering teleradiology, on-site imaging equipment, and FDA-cleared AI software to independent practices, hospitals, and health systems nationally. The company operates a network of 95+ board-certified radiologists and sub-specialists across 50 states (active licenses), serving 3.5 million patients in 23 states. Core offerings include: (1) In-Clinic Imaging—permanent, in-office diagnostic imaging equipment with end-to-end support and program deployment; (2) AI-Enabled Interpretations—U.S.-based subspecialized clinicians augmented with proprietary FDA-cleared AI algorithms for improved diagnostic accuracy, consistency, and turnaround time; (3) Advanced Imaging Analytics (RadGap)—AI-driven image and report analytics for payers, providers, and risk-bearing entities to identify and close care gaps. The company positions itself as a partnership model between diagnosticians and ordering physicians, emphasizing 24/7 support, rapid turnaround, and clinical outcomes: 73% reduction in life-threatening misses (chest imaging), 100% improvement in chronic disease identification, and 97% all-time customer retention. Imagen manufactures or deploys diagnostic imaging hardware on-site and develops AI software for image interpretation and population health analytics. FDA clearances include AI algorithms; specific regulatory pathways (510(k), De Novo) not detailed in available content.